Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Lonza Expands Viral-Based Therapeutics Business with New cGMP Unit at Houston
2:15 AM MDT | May 18, 2011 | Natasha Alperowicz
Lonza says it will expand its viral-based therapeutics business with the construction of a new cGMP clean room adjacent to its existing Houston operations. The facility will offer large-scale capacity to support late-stage viral vaccine and gene therapy projects. It will use disposable process systems and be able to support production anf fill/finish operations of up to 2,000 liters. Enhanced, EU compliant, fill and finish capabilities are in high demand from Lonza's pharma and biotech customers, the company says. The expansion will also reduce Lonza's clients'...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee